These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 30115078)

  • 1. KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc.
    Li J; Liu Q; Liu Z; Xia Q; Zhang Z; Zhang R; Gao T; Gu G; Wang Y; Wang D; Chen X; Yang Y; He D; Xin T
    J Exp Clin Cancer Res; 2018 Aug; 37(1):194. PubMed ID: 30115078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of miR-26 as a key mediator of estrogen stimulated cell proliferation by targeting CHD1, GREB1 and KPNA2.
    Tan S; Ding K; Li R; Zhang W; Li G; Kong X; Qian P; Lobie PE; Zhu T
    Breast Cancer Res; 2014 Apr; 16(2):R40. PubMed ID: 24735615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Enhancer of Zeste Homolog 2 (EZH2) Expression on Brain Glioma Cell Proliferation and Tumorigenesis.
    Cheng T; Xu Y
    Med Sci Monit; 2018 Oct; 24():7249-7255. PubMed ID: 30305602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a.
    Huang L; Wang HY; Li JD; Wang JH; Zhou Y; Luo RZ; Yun JP; Zhang Y; Jia WH; Zheng M
    Cell Death Dis; 2013 Aug; 4(8):e745. PubMed ID: 23907459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing KPNA2 inhibits IL-6-induced breast cancer exacerbation by blocking NF-κB signaling and c-Myc nuclear translocation in vitro.
    Duan M; Hu F; Li D; Wu S; Peng N
    Life Sci; 2020 Jul; 253():117736. PubMed ID: 32360571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative proteomics reveals regulation of karyopherin subunit alpha-2 (KPNA2) and its potential novel cargo proteins in nonsmall cell lung cancer.
    Wang CI; Chien KY; Wang CL; Liu HP; Cheng CC; Chang YS; Yu JS; Yu CJ
    Mol Cell Proteomics; 2012 Nov; 11(11):1105-22. PubMed ID: 22843992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-1297 negatively regulates metabolic reprogramming in glioblastoma via repressing KPNA2.
    Li H; Yuan H
    Hum Cell; 2020 Jul; 33(3):619-629. PubMed ID: 32124270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PKM2 promotes glucose metabolism and cell growth in gliomas through a mechanism involving a let-7a/c-Myc/hnRNPA1 feedback loop.
    Luan W; Wang Y; Chen X; Shi Y; Wang J; Zhang J; Qian J; Li R; Tao T; Wei W; Hu Q; Liu N; You Y
    Oncotarget; 2015 May; 6(15):13006-18. PubMed ID: 25948776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
    Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
    J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Myc and let-7a in glioblastoma, glucose metabolism and response to therapy.
    Wang G; Wang J; Zhao H; Wang J; Tony To SS
    Arch Biochem Biophys; 2015 Aug; 580():84-92. PubMed ID: 26151775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactic acid induces lactate transport and glycolysis/OXPHOS interconversion in glioblastoma.
    Duan K; Liu ZJ; Hu SQ; Huo HY; Xu ZR; Ruan JF; Sun Y; Dai LP; Yan CB; Xiong W; Cui QH; Yu HJ; Yu M; Qin Y
    Biochem Biophys Res Commun; 2018 Sep; 503(2):888-894. PubMed ID: 29928884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing VDAC1 expression induces a non-apoptotic role for pro-apoptotic proteins in cancer cell differentiation.
    Arif T; Krelin Y; Shoshan-Barmatz V
    Biochim Biophys Acta; 2016 Aug; 1857(8):1228-1242. PubMed ID: 27080741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotensin signaling stimulates glioblastoma cell proliferation by upregulating c-Myc and inhibiting miR-29b-1 and miR-129-3p.
    Ouyang Q; Chen G; Zhou J; Li L; Dong Z; Yang R; Xu L; Cui H; Xu M; Yi L
    Neuro Oncol; 2016 Feb; 18(2):216-26. PubMed ID: 26180082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone demethylase KDM4C controls tumorigenesis of glioblastoma by epigenetically regulating p53 and c-Myc.
    Lee DH; Kim GW; Yoo J; Lee SW; Jeon YH; Kim SY; Kang HG; Kim DH; Chun KH; Choi J; Kwon SH
    Cell Death Dis; 2021 Jan; 12(1):89. PubMed ID: 33462212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Imaging Detects Low Levels of Glycolytic Activity That Vary with Levels of c-Myc Expression in Patient-Derived Xenograft Models of Glioblastoma.
    Mair R; Wright AJ; Ros S; Hu DE; Booth T; Kreis F; Rao J; Watts C; Brindle KM
    Cancer Res; 2018 Sep; 78(18):5408-5418. PubMed ID: 30054337
    [No Abstract]   [Full Text] [Related]  

  • 16. NKAP alters tumor immune microenvironment and promotes glioma growth via Notch1 signaling.
    Gu G; Gao T; Zhang L; Chen X; Pang Q; Wang Y; Wang D; Li J; Liu Q
    J Exp Clin Cancer Res; 2019 Jul; 38(1):291. PubMed ID: 31277684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc.
    Masui K; Tanaka K; Akhavan D; Babic I; Gini B; Matsutani T; Iwanami A; Liu F; Villa GR; Gu Y; Campos C; Zhu S; Yang H; Yong WH; Cloughesy TF; Mellinghoff IK; Cavenee WK; Shaw RJ; Mischel PS
    Cell Metab; 2013 Nov; 18(5):726-39. PubMed ID: 24140020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas.
    Miranda-Gonçalves V; Granja S; Martinho O; Honavar M; Pojo M; Costa BM; Pires MM; Pinheiro C; Cordeiro M; Bebiano G; Costa P; Reis RM; Baltazar F
    Oncotarget; 2016 Jul; 7(29):46335-46353. PubMed ID: 27331625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDCA7L promotes glioma proliferation by targeting CCND1 and predicts an unfavorable prognosis.
    Ji QK; Ma JW; Liu RH; Li XS; Shen FZ; Huang LY; Hui L; Ma YJ; Jin BZ
    Mol Med Rep; 2019 Aug; 20(2):1149-1156. PubMed ID: 31173217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-135a-5p Functions as a Glioma Proliferation Suppressor by Targeting Tumor Necrosis Factor Receptor-Associated Factor 5 and Predicts Patients' Prognosis.
    Luo W; Sun C; Zhou J; Wang Q; Yu L; Bian XW; Zhou X; Hua D; Wang R; Rao C; Jiang Z; Shi C; Yu S
    Am J Pathol; 2019 Jan; 189(1):162-176. PubMed ID: 30312580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.